PRA Health Sciences Launches New Initiative to Bolster Workforce

Food and Healthcare Press Releases Tuesday July 21, 2015 08:20
RALEIGH, N.C.--(GLOBE NEWSWIRE)--July 20, 2015

PRA Health Sciences (PRA) (NASDAQ:PRAH) is looking to hire new talent. To help attract potential employees from around the world, PRA, a leading global contract research organization (CRO), is launching a new Candidate Experience initiative. Just as PRA is finding innovative ways to improve the clinical development process, it is also developing creative strategies to meet the ever-growing need to identify highly skilled clinical research employees.

"The CRO industry requires many unique skill sets and finding the right talent can be a challenge," said PRA Vice President of Talent Acquisition Glenn Sward. "PRA's new Candidate Experience initiative is designed to attract the highest caliber talent and give potential employees a comprehensive view of our culture and the many rewards of working in an industry that helps bring life-saving drugs to market."

The Candidate Experience includes a new website (www.discoveryourpra.com) which features profiles and videos of a small cross section of current PRA employees. The profiles are designed to give candidates a unique glimpse into clinical development work and why employees find it meaningful. It also includes information about the many benefits of working for PRA.

The Candidate Experience complements several other PRA initiatives, including its highly successful Bridge Program which addresses the pressing need to recruit qualified clinical research associates (CRAs). "The tremendous growth of our industry is driving the demand for more CRAs," said Sward. "PRA's Bridge Program is an innovative training program that transitions qualified RNs, study coordinators, and allied health professionals to a CRA role."

PRA's Oncology University was also developed to respond to the industry need for oncology-experienced CRAs. The program trains experienced CRAs, giving them the knowledge and skills to handle the specific demands of oncology clinical studies. In addition, the PRA Program was created to give recent college graduates a hands-on view of career opportunities within PRA, and to identify promising candidates and streamline them into clinical studies.

The PRA Candidate Experience helps candidates learn more about PRA's people and culture. It is another step in helping to identify talented individuals who may become part of PRA's future workforce - a workforce that is dedicated to advancing drug discovery and improving patients' lives.

ABOUT PRA HEALTH SCIENCES

At PRA Health Sciences, providing innovative solutions for our clients is what we do. Side-by-side with our clients, we strive to move drug discovery forward, helping them to develop life-saving and life-improving drugs. PRA has more than 11,000 employees working in 80+ countries providing comprehensive clinical development services across all phases. From full service clinical development to the pioneering Embedded Solutions(TM) model, PRA provides a broad spectrum of solutions that meet the demands of a diverse marketplace. PRA has worked on 100+ marketed drugs across several therapeutic areas and conducted the pivotal or supportive trials that led to FDA and/or international regulatory approval of 50+ such drugs.

CONTACT: INQUIRIES:
Christine Rogers, Manager - Public Relations,
Corporate Communications
EMAIL: rogerschristine@prahs.com
PHONE: +1 919.786.8463
Global Headquarters
4130 ParkLake Avenue,
Suite 400
Raleigh, North Carolina USA
PHONE: +1 919.786.8200
www.prahs.com

Latest Press Release

Walgreens Boots Alliance and Microsoft establish strategic partnership to transform health care delivery

- Companies aim to improve health outcomes and lower overall costs with enhanced digital and retail experiences and an R&D commitment to build health care solutions through seven-year agreement Walgreens Boots Alliance Inc. (WBA) and Microsoft Corp....

Ascensia Diabetes Care Announces Global Partnership With POCTech to Distribute and Co-develop Continuous Glucose Monitoring Systems

Ascensia Diabetes Care today announced it has entered into a global alliance with Zhejiang POCTech, Co., Ltd (POCTech), a developer and manufacturer of continuous glucose monitoring (CGM) systems. (Logo:...

MGI Announces Milestone of 1,000 Sequencers Installed and Opens Early Access Program for Groundbreaking Ultra-High-Throughput Sequencer, MGISEQ-T7

MGI, established in 2016 as a subsidiary of global genomics leader BGI Group, announced it has reached a new milestone of 1,000 MGI sequencers installed in 16 countries. MGI Chief Operating Officer Dr. Hui Jiang also announced the availability of MGI's...

Gift of Life Donor Program is U.S. Leader in Saving Lives

For the 11th consecutive year, Gift of Life Donor Program is the nation's leading organ procurement organization (OPO), coordinating the most life-saving organs for transplant among all 58 U.S. OPOs. Gift of Life broke two national records in 2018,...

Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat

Licensing rights are worldwide excluding US, Canada, Japan and South AmericaHelsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Menarini, an Italian biopharmaceutical Group active in 136 countries worldwide, today...

Related Topics